Product Information
TERIPARATIDE 560 MCG/2.24 ML PEN is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $494.8050 per ML under NDC 00093110616. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Nov 16, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 ug/mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093110616
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
TERIPARATIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA208569FDA Approved
11/16/2023
TE Code
AP
On Market Since
12/18/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $494.8050 per ML |
|---|---|
| All-time high | $899.9994 (Nov 13, 2024) |
| All-time low | $494.8050 (Aug 19, 2026) |
| 52-week high | $846.0749 |
| 52-week low | $494.8050 |
| Median price | $710.1533 |
| Average price | $728.0769 |
| Largest weekly change | -20.7% (Oct 22, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERIPARATIDE 560 MCG/2.24 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TERIPARATIDE 560 MCG/2.24 ML PEN, manufactured by Teva Pharmaceuticals USA Inc., is $494.8050 per ML (NDC 00093110616), effective Aug 19, 2026.
How has the price of TERIPARATIDE 560 MCG/2.24 ML PEN changed over time?
Over the history we have for it, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has declined 30.3%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TERIPARATIDE 560 MCG/2.24 ML PEN?
Since Apr 17, 2024, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has ranged from a low of $494.8050 (Aug 19, 2026) to a high of $899.9994 (Nov 13, 2024), with a median of $710.1533 per ML.
Are there cheaper alternatives to TERIPARATIDE 560 MCG/2.24 ML PEN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIPARATIDE 560 MCG/2.24 ML PEN in a comparable dosage form, but none are currently priced below it.
Who manufactures TERIPARATIDE 560 MCG/2.24 ML PEN?
TERIPARATIDE 560 MCG/2.24 ML PEN (NDC 00093110616) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.